Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
ALPCO Appoints Stratech Scientific as Their New Distribution Channel in the UK
Stratech Scientific is a distributor of high quality products for research laboratories throughout the UK and Europe. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - August 13, 2009 - ALPCO
Drug-Device Combination Market Worth US $18.54 Billion by 2014
Market of Drug-device combination is expected to be worth US $18.54 billion by 2014 - August 07, 2009 - marketsandmarkets
XTractor Premium Surpasses 200,000 Mark of Expert Annotated PubMed Facts
Molecular Connections announced today, that their XTractor Premium platform surpasses 200,000 "Expert" annotated facts from PubMed. - August 07, 2009 - Molecular Connections Pvt. Ltd.
Advances in Ovarian Tumor Therapy Made at the Lankenau Institute for Medical Research - Cancer Research Paper Shows Nanoparticle Delivery System Slowed Ovarian Tumor Grow
Dr. Janet Sawicki, Professor at the Lankenau Institute for Medical Research (LIMR), along with its collaborating institution, the Massachusetts Institute of Technology (MIT), published a paper in Cancer Research whose findings suggest a potential new therapy to treat advanced stage ovarian cancer. - August 01, 2009 - Lankenau Institute for Medical Research
International Cellular Medicine Society Seeks to Educate Patients on Off-Shore Stem Cells Clinics
Stem cell clinics in nearly 20 countries have been actively advertising new stem cell therapies for a myriad of diseases ranging from congestive heart failure to ALS. To help patients, the ICMS has launched a comprehensive study of promises and downsides of off shore stem cell therapies and clinics. - July 19, 2009 - International Cellular Medicine Society
Dr. Patrick Bitter, Sr. M.D. Joins Vascular Health Specialists
After several months of in-depth collaboration, Dr. Patrick Bitter Sr., a dermatologist and rosacea treatment expert, has joined Vascular Health Specialists LLC. - June 26, 2009 - Vascular Health Specialists LLC
North American Seminars, Inc. Is Looking for Medical Professionals and Medical Content Writers and Researchers
North American Seminars, Inc. is expanding and looking for medical professionals to assist in the creation of educational material and present live education training across the United States and Europe. - June 16, 2009 - North American Seminars
168 Electronic Cigarette Users Give Their Opinions in E Cigarette Direct Survey
In an E Cigarette Direct survey Electronic Cigarette Users voice their opinion on the electronic cigarette, their health, quitting and the upcoming US ban on the device. - June 14, 2009 - Gower Entreprises
Lankenau Institute for Medical Research Investigator Receives March of Dimes Grant: Research Focused on Congenital Defects of the Eye in Newborns Using a Stem Cell Model
Dr. Mindy George-Weinstein, Professor at the Lankenau Institute for Medical Research (LIMR), in collaboration with Dr. Sue Menko, Professor at Thomas Jefferson University, received a three-year grant in the amount of $264,410 from the March of Dimes to study the development of eye defects that may lead to cataracts, glaucoma, increased sensitivity to light, squinting or blindness in newborns. - June 13, 2009 - Lankenau Institute for Medical Research
Mighty Microbes Launches Updated Website
Mighty Microbes, featuring probiotics to boost your immune system, enhance your energy and promote overall better health, has announced the launch of their updated website http://www.MightyMicrobes.com. - June 13, 2009 - Mighty Microbes
Hereditary Neuropathy Foundation Announces Major Research Effort
The Hereditary Neuropathy Foundation announced today that it will be funding a major research effort to find a cure for Charcot-Marie-Tooth disease. - June 12, 2009 - Hereditary Neuropathy Foundation
Integrated Clinical Trial Services Releases White Paper On Medical Science Liaisons (MSL)
Tom Sturgis, president of ICTS (Integrated Clinical Trial Services), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and pharmaceutical development, has announced the release... - June 10, 2009 - Integrated Clinical Trial Services
S.L.E. Lupus Foundation, 1st Lupus Organization Ever Selected as Charity Partner for ING New York City Marathon
The S.L.E. Lupus Foundation has been selected as an official charity for the ING New York City Marathon 2009, making it the first lupus organization ever to host a team in this famous race that has a broadcast reach to more than 300 million people worldwide. The Foundation currently has 25 openings for runners to participate in their “Team Life Without Lupus.” - June 09, 2009 - S.L.E. Lupus Foundation
ENCO Pharmaceutical Development Announces Addition of Keith Hurley as Vice-President of Sales and Marketing
ENCO Pharmaceutical Development, Inc. is pleased to announce the addition of Mr. Keith Hurley to its staff as Vice-President of Sales and Marketing. - June 06, 2009 - Enco Pharmaceutical Development, Inc.
42 market research Shortlisted for TECOM Investments Pearl Award
42 market research, a leading market research provider for the healthcare industry, has been shortlisted by TECOM Investments for the Pearl Award for Globalisation and Diversification. “The achievement of 42 market research is highly commendable and to be shortlisted in the category of... - June 05, 2009 - 42 market research
Infonetica Announce Launch of Online GCP Training for USA
Infonetica is happy to announce the launch of a US online GCP training satisfying ICH and FDA criteria, which are essential to Good Clinical Practice regulations. - May 24, 2009 - Infonetica Ltd
Flexfit Supports Mauli Ola Foundation as a Title Sponsor to Benefit Kids with Cystic Fibrosis
Flexfit headwear is a title sponsor of Mauli Ola Foundation’s 2009 Surf Experience Day events to benefit children and young adults with cystic fibrosis. - May 21, 2009 - Flexfit
MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced it has been awarded a service contract to manage a 50-center, multi-national, late phase epilepsy trial. The Houston-based CRO with regional offices in Raleigh, NC, will provide Project... - May 15, 2009 - MedSource
Unbound Medicine Releases Medical Applications for Android™ Mobile Platform -- Point-of-Care Information Available for Phones with Google Operating System
Today, Unbound Medicine, a leader in knowledge management solutions for healthcare, announced the availability of premier medical references for smartphones running the Android™ mobile technology platform from Google, Inc. The Unbound™ Platform already supports native applications for... - May 14, 2009 - Unbound Medicine
Nationwide American Cancer Society Study Looks to Union & Middlesex County, NJ for Participants
New Jersey Residents Can Have Direct Impact on Cancer Research. A Little of your time can make a Huge difference in the Fight Against Cancer. - May 06, 2009 - American Cancer Society Relay For Life of Rahway NJ
ENCO Analytix, Inc, Announces Name Change to ENCO Pharmaceutical Development, Inc.
ENCO Analytix, Inc. announced today that effective immediately the company name will change to ENCO Pharmaceutical Development, Inc. - May 03, 2009 - Enco Pharmaceutical Development, Inc.
RNCOS Releases a New Report- Clinical Trials Market in Russia
RNCOS has recently added a new Market Research Report titled, “Clinical Trials Market in Russia” to its report gallery. This report provides extensive research and thorough analysis of the Russia Clinical Trials Market. - May 03, 2009 - RNCOS
GoOn Research and Development Project Wins Theseus-Mittelstand
Proposed by Transinsight, RESprotect, Antikörper-Online, and TU Dresden, the GoOn project will focus on developing semantic technologies for the biomedical domain. - May 02, 2009 - Transinsight
New Clinical Trial Testing if Dietary Changes Can Help Patients with Crohn's Disease
The research group of Dr. James Michael Mullin, Professor at the Lankenau Institute for Medical Research (LIMR), is conducting a clinical trial for patients with Crohn’s Disease. Past work of Dr. Mullin’s group has shown that dietary restriction of the amino acid methionine can improve the junctional seals between epithelial cells. This holds the promise that dietary restriction of methionine may be able to improve intestinal linings of Crohn’s patients, thereby reducing their disease symptoms. - April 26, 2009 - Lankenau Institute for Medical Research
MedPro Rx Launches New Web Site for Children with Bleeding Disorders
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that the pharmacy has launched a Web site for kids (www.medprorx.com/kids/index-flash.html). The new site provides a fun and interactive... - April 24, 2009 - MedPro Rx, Inc.
The Journal of the Unpublished (JUNPonline.com) Goes Live
Amateur and professional scientist's can now publish all their observations, data and scientific research through easy to use forms for free. The goal of JUNP is to publish and share research that normally would not make it into traditional journals. - April 07, 2009 - Wildlife Sightings
Pivotal Study to Focus on System to Repair Knee Cartilage Damage
Craig Levitz, MD, South Nassau's chairman of Orthopedics and director of South Nassau's Center for Advanced Orthopedics, is among a group of orthopedic surgeons in the United States that is enrolling candidates for a multi-center, randomized, pivotal clinical trial that will evaluate the safety and efficacy of CAIS for the surgical treatment of articular cartilage tears (lesions) of the knee. - April 04, 2009 - Mount Sinai South Nassau
42 Market Research Launches Online Interviews for Pharmaceutical Research in Brazil and Mexico
The market research agency, 42 market research, is now offering online interviews in Brazil and Mexico, and so continues to expand its leading position in online market research for the healthcare industry. - April 04, 2009 - 42 market research
Can Cherries Relieve the Pain of Osteoarthritis? Patients in Pilot Study of Cherry Pills Experience Significant Pain Relief
For the estimated 27 million Americans who suffer from osteoarthritis, pain relief may come with a cherry on top. According to researchers with the Baylor Research Institute, tart cherries, in pill form, may be a promising pain-reliever for this common and debilitating form of arthritis. - March 27, 2009 - Baylor Research Institute
Dr. Russell Thomas at The Hamner Receives Society of Toxicology Achievement Award
The Hamner Institutes for Health Sciences (The Hamner) has announced that Russell S. Thomas, Ph.D., director of the Center for Genomic Biology and Bioinformatics and senior investigator at The Hamner, has received the 2008 Achievement Award from the Society of Toxicology. The award honors a member... - March 18, 2009 - The Hamner Institutes for Health Sciences
Sleep Machine Provides Magnetic Solution for Poor Quality Sleep
The Sleep on Command™ Sleep Machine offers consumers a natural way to fall asleep faster, stay asleep longer and wake up feeling more rejuvenated than ever before. The Sleep on Command™ Sleep Machine uses technology based upon natural Earth generated frequencies. These naturally occurring frequencies correlate perfectly with the mind’s stress free brain-wave spectrum. The lowest end of that spectrum correlates perfectly with deep Delta-rhythm sleep. - March 12, 2009 - EarthPulse Tech, LLC
Lankenau Institute for Medical Research Accelerates New Nanotherapy Platform for Treatment of Solid Tumors - Novel Delivery System Enters Preclinical Development Phase
The Lankenau Institute for Medical Research (LIMR) and its collaborating institution, the Massachusetts Institute of Technology (MIT), announced on March 9, 2009, that LIMR has been selected by the National Cancer Institute (NCI) for a research collaboration to perform preclinical studies on novel therapeutic nanoparticles for treatment of solid tumors. The research will be conducted by the NCI’s Nanotechnology Characterization Laboratory (NCL). - March 11, 2009 - Lankenau Institute for Medical Research
Dr. Charles Hamner Leads CED Biotech Forum
The Hamner Institutes for Health Sciences (www.thehamner.org) has announced that Dr. Charles Hamner, Chair of the Board of Directors, will be the moderator for the Council for Entrepreneurial Development (CED) Biotech Forum on Monday, March 16, entitled “Translating Clinical Needs into... - March 11, 2009 - The Hamner Institutes for Health Sciences
Early Phase Clinical Trials Leader Unveil Their New Portal to Comprehensive Clinical Trials Data Management
Richmond Pharmacology today launched their clinical trials data management portal signalling the establishment of a new era in clinical trials data management at Richmond Pharmacology. Designed by Data Management professionals from the Pharmaceutical industry with the needs of the Pharmaceutical industry in mind. - March 10, 2009 - Richmond Pharmacology Ltd
The Hamner Institutes Hosts “PBPK Modeling in Drug Development and Evaluation” Workshop
The Hamner Institutes for Health Sciences (www.thehamner.org) will host “Physiologically Based Pharmacokinetic Modeling (PBPK) In Drug Development and Evaluation,” a workshop scheduled for April 6-10 in Alexandria, Va. The seminar, sponsored by The Hamner-University of North Carolina... - March 07, 2009 - The Hamner Institutes for Health Sciences
Genescient and Kronos Announce Alzheimer's Disease Collaboration
Genescient Corporation and Kronos Science Laboratory will work together to analyze the Kronos Alzheimer's Case-Control Database, considered to be the finest Alzheimer's Disease genetic data set in the US. The companies hope to identify genes previously unrecognized genes that are involved in Alzheimer's Disease. - March 04, 2009 - Genescient Corporation
Announcing the Launch of the New 25-OH Vitamin D ELISA: Exceptional Correlation to LC-MS/MS in a User-Friendly, Automatable ELISA Format
Serum measurements of 25-OH vitamin D by ELISA are easy and cost-effective for research laboratories who do not have access to the gold standard method, LC-MS/MS with the new 25-OH vitamin D ELISA kit offered by ALPCO. - February 27, 2009 - ALPCO
Depression Doubles Negative Health Risks for African-American Men
African-American men suffering depression are more than twice as likely to die within a year after suffering a heart attack, according to research in a new book, "Say It Loud! I'm Black and I'm Depressed." More than 2 million black men in the US suffer depression and heart disease is just one of the killer illnesses it affects. "Say It Loud," reveals the seriousness of the situation. - February 11, 2009 - Say It Loud
Paper Reveals Potential New Treatment for Ovarian Cancer
Ovarian cancer is the fourth most common cancer in women and has the highest mortality rate for gynecologic cancers because it is often diagnosed at an advanced stage. New effective therapies for the treatment of advanced stage ovarian cancer are urgently needed. A paper published February 9,... - February 11, 2009 - Lankenau Institute for Medical Research
GeneFluidics Inc. Proteus Robotic System Receives ALA New Product Award
GeneFluidics, Inc. is pleased to announce that their Proteus Robotic System has received the New Product Award from the Association for Laboratory Automation (ALA) at LabAutomation2009. The ALA is an international organization devoted to the study, development, and use of laboratory automation. - February 03, 2009 - GeneFluidics Inc.
RPost Builds New Healthcare Solutions Practice in Response to Growing Industry Demand to Shorten Cycle Times and Reduce Cost
Premier physician, researcher and innovator joins RPost team to build specialized healthcare practice and bring company’s platform of cost-cutting and time-saving tools to the pharmaceutical, medical device, and care provider firms worldwide. - January 28, 2009 - RPost
IonSense Announces the Expansion of DART® Ion Source Product Line to Include TOF Mass Spectrometers
The Popular Direct Analysis Technique is Now Available for Time-of-Flight Instruments, Expanding the Range of Applications. - January 27, 2009 - IonSense, Inc.
Competitive Technologies Announces Sales Order from ELS for Pain Management Devices
We have seen this device in action, and have witnessed its pain relieving capabilities. ELS is starting formal clinical studies using this new pain management device at four leading healthcare facilities in India within the month. - January 17, 2009 - Excel Life Sciences
LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage
LegalView recently reported the results of a scientific study in which victims of a brain injury were more likely to report strong spiritual associations. The researchers found that feelings of spirituality might actually be caused by brain damage among victims and trauma caused to the right parietal lobe. - January 14, 2009 - LegalView
Is Hair Loss Caused by Skull Expansion?
A new study suggests that people who agonize over hair loss (androgenetic alopecia) might actually have skull expansion (skull bone growth) to blame. A UK researcher has determined that men and women whose skull bones keep growing during adulthood are far more likely to develop hair thinning, hair loss and baldness. - January 12, 2009 - HairGrowthSOS.com
Integrated Clinical Trial Services Launches Medical Science Liaison Program
Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced that the firm has launched its... - January 04, 2009 - Integrated Clinical Trial Services
Charles Peterfy, Chief Scientific Officer at Synarc to Give Featured Presentation at GTCbio’s 4th Imaging in Preclinical & Clinical Drug Development Conference
Charles Peterfy, Chief Scientific Officer at Synarc will give the featured presentation at GTCbio’s 4th annual Imaging in Preclinical & Clinical Drug Development Conference on March 16-17, 2009 in San Francisco, CA. - January 02, 2009 - GTCbio
The Hamner Institutes for Health Sciences Receives $2.1 Million Asbestos Research Grant
The Hamner Institutes for Health Sciences (www.thehamner.org) has announced that it has received a contract totaling $2.1 million from the U.S. Environmental Protection Agency to study vermiculite (or Libby amphibole), a mineral resembling mica used in insulation, packing and other processes. A... - December 21, 2008 - The Hamner Institutes for Health Sciences
World AIDS Day: HIV Treatment Patterns Consistent in Practice, QuantiaMD Finds
A national survey of HIV clinicians conducted by Dr. John Bartlett on QuantiaMD reveals important details about treatment patterns for HIV patients since the introduction of the Department of Health and Human Services (DHHS) 2007 federal HIV guidelines. - December 02, 2008 - Quantia Communications, Inc.
S.L.E. Lupus Foundation Gala Celebrates Families United for a Cure
Mayor Bloomberg, South Pacific Star Kelli O’Hara, and CBS broadcaster Charles Osgood pay tribute to families at the S.L.E. Lupus Foundation's "Life Without Lupus" Gala on November 20, 2008. The nation’s largest annual benefit for lupus, held at the Marriott Marquis in New York City, raised millions of dollars for patient services, community outreach, and research to find better treatments and a cure for the systemic autoimmune disease. - November 25, 2008 - S.L.E. Lupus Foundation